# Pilot Trial: Comparing Buzzy to Intradermal Lidocaine for Peripheral IV Cannulation in Adults

> **NCT04647084** · PHASE4 · WITHDRAWN · sponsor: **Steward St. Elizabeth's Medical Center of Boston, Inc.**

## Conditions studied

- Pain, Acute
- Patient Satisfaction

## Interventions

- **DRUG:** Lidocaine 2% Injectable Solution
- **DEVICE:** Buzzy

## Key facts

- **NCT ID:** NCT04647084
- **Lead sponsor:** Steward St. Elizabeth's Medical Center of Boston, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-10-15
- **Primary completion:** 2024-10-15
- **Final completion:** 2025-05-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The investigators were unable to begin work on this study.
- **Last updated:** 2023-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04647084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04647084, "Pilot Trial: Comparing Buzzy to Intradermal Lidocaine for Peripheral IV Cannulation in Adults". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04647084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*